News

INTREPID Alliance Forms Advisory Board for Antiviral Advancements

INTREPID Alliance Forms Advisory Board for Antiviral Advancements

INTREPID Alliance Forms Scientific Advisory Board

The INTREPID Alliance, a consortium comprised of innovative biopharmaceutical companies, is focused on advancing antiviral treatments to bolster global health in preparation for future pandemics. Recently, the alliance has officially announced the formation of its Scientific Advisory Board (SAB), which will be pivotal in steering efforts toward accelerating the discovery and development of antiviral therapies against emerging viral agents.

Objectives of the Scientific Advisory Board

The primary focus of the SAB will be to provide expert guidance to INTREPID regarding antiviral research priorities. Its members, composed of distinguished professionals in infectious disease research, drug development, and public health, will advise on emerging trends in the field, help shape program strategies, and tackle significant scientific challenges.

Strategic Endeavors for Pandemic Preparedness

By interpreting vital landscape data and utilizing their expertise, the SAB will enhance INTREPID's long-term strategies aimed at improving preparedness for pandemics. This initiative is crucial as the world continues to face new viral threats, making it imperative for the scientific community to work collaboratively.

Introducing the Chair of the Board

Leading the advisory board is Ruxandra Draghia-Akli, M.D., Ph.D., who was appointed earlier this year. Dr. Draghia-Akli boasts an impressive background in public health, with a history of developing pioneering healthcare solutions. She is set to become the Executive Vice President and Head of Research and Development at Novavax.

Dr. Draghia-Akli’s Vision for Antiviral Research

In her inaugural message, Dr. Draghia-Akli expressed her excitement about her new role and emphasized the importance of antiviral treatments in bolstering global defenses against viruses. She voiced a strong commitment to addressing current gaps in the antiviral pipeline. Her goal is to work with INTREPID and its esteemed SAB members to enhance the research and development landscape for viral treatments, ensuring better readiness for future health crises.

Meet the Members of the Advisory Board

The SAB features an array of accomplished individuals, each bringing unique expertise and experience to the table:

Dr. Constance Benson

A clinician and researcher recognized for her work in HIV and tuberculosis, Dr. Benson is a Professor of Medicine and Global Public Health at the University of California San Diego. She has been pivotal in managing major clinical trials and is dedicated to advancing viral health treatments.

Dr. Kelly Chibale

Holding the Neville Isdell Chair in African-centric Drug Discovery, Dr. Chibale is a Professor at the University of Cape Town. His research is focused on discovering new drugs for infectious diseases, with a spotlight on improving health outcomes for populations of African descent.

Dr. Barry Clinch

A consultant with extensive experience in clinical development strategy, Dr. Clinch has worked in the biopharmaceutical sector for 25 years and has played a key role in the development of vaccines and antivirals.

Dr. Ken Duncan

As the Deputy Director of Discovery and Translational Sciences at the Gates Foundation, Dr. Duncan focuses on drug discovery programs, particularly in tuberculosis and malaria, addressing significant global health challenges.

Dr. Daria Hazuda

A veteran in infectious disease research, Dr. Hazuda is currently at Generate:Biomedicines. Her history at Merck was instrumental in the development of crucial antiviral therapies and vaccines.

Dr. Johan Neyts

Professor of Virology at KU Leuven, Dr. Neyts specializes in creating antiviral treatments and is known for his contributions in the field of neglected viral infections.

About the INTREPID Alliance

The INTREPID Alliance aims to expedite the development of innovative treatments for viral pandemic agents. By consolidating knowledge from the public and private sectors, the alliance is positioned to address critical gaps in antiviral solutions, ensuring effective responses to future threats. The launch of the INTREPID Alliance reflects a proactive approach in engaging a wide range of stakeholders dedicated to public health.

Frequently Asked Questions

What is the purpose of the INTREPID Alliance?

The INTREPID Alliance is focused on accelerating the development of treatments for viral pandemic agents, ensuring the world is prepared for future threats.

Who chairs the Scientific Advisory Board?

Dr. Ruxandra Draghia-Akli is the inaugural chair of the Scientific Advisory Board, bringing extensive experience in public health.

What expertise do the SAB members have?

The SAB comprises experts in virology, infectious diseases, drug discovery, and public health, contributing to a wide-ranging knowledge base.

How will the SAB support pandemic preparedness?

The SAB will guide research priorities, inform strategies, and enhance collaboration to ensure robust responses to viral threats.

Why are antiviral treatments important?

Antiviral treatments are crucial for protecting global health, providing defense against both emerging and existing virus threats.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Securitize Tests the IPO Clock With Anthropic Tokens

Updated Category News Views 81

Anthropic did not even get a full trading day to itself before the tokenization crowd arrived. Securitize says Anthropic stock became available through Securitize Stocks on Solana on the company’s first day as a public company, a loud little signal that the old IPO playbook is being prodded from the edges. For investors, this is not merely another crypto-flavored...

Continue Reading
JLL’s Facility Management Push Gets a Useful Nod From Frost

Updated Category News Views 123

A Building Breaks Down Long Before the Earnings Call Notices Facility management is the sort of business that gets ignored until an airport system fails, a data-center cooling unit balks, or a workforce cannot use the building it was told to return to. That is why Frost & Sullivan’s 2026 recognition of JLL deserves more than the usual award-season shrug. It points to an...

Continue Reading
Borr’s Q3 Presentation Puts Jack-Up Investors on Watch

Updated Category News Views 93

Jack-up drilling is a rough business to judge from a calendar invite, but Borr Drilling has put a useful marker in the sand. The company is scheduled to present financial results for the three and nine months ended September 30, 2026, at 09:00 New York time, or 15:00 CET, on Thursday, November 19. For holders of BORR, this is less about ceremonial webcast chatter and more...

Continue Reading
Innogen's Arcera Deal Tests Its GLP-1 Global Reach

Updated Category News Views 115

A License Deal With Actual Cash Attached Drug licensing announcements can smell like expensive perfume: plenty of promise, hard to tell what is really in the bottle. This one at least arrives with a concrete number. Innogen Pharmaceuticals will receive US$38 million in upfront and near-term milestone payments from Arcera Life Sciences for Efsubaglutide Alfa, including a...

Continue Reading
Ductless Mini-Splits Put HVAC Efficiency Into Focus

Updated Category News Views 38

Ductless mini-splits have slipped from contractor jargon into a serious conversation about how homes and smaller buildings are heated and cooled. That is the worthwhile backdrop for a HelloNation article featuring HVAC expert Natasha Adams. The source notes are lean—really lean—and do not spell out her specific guidance, product comparisons, efficiency figures,...

Continue Reading
Fromm Day Marks 50 Years of Learning and Connection

Updated Category News Views 37

A city proclamation can be fluffy civic confetti, but this one lands differently. San Francisco declared Nov. 14, 2026, Fromm Day as the Fromm Institute for Lifelong Learning marked its 50th anniversary, and the underlying story is sturdier than a ceremonial photo op. A program that began in 1976 expecting roughly 50 people at an open house drew about 150 students in its...

Continue Reading
TDH's First-Half Revenue Grew, but Margins Vanished

Updated Category News Views 41

A rental business can add tenants and still march backward, and TDH Holdings just demonstrated the ugly math. For the six months ended June 30, 2026, revenue from continuing operations rose 26.45% to $0.74 million. That is the pleasant number, and it deserves exactly one polite nod. Everything beneath it looks far less comfortable: costs climbed faster than revenue, gross...

Continue Reading
Minno Bets on Listener Kids to Build Premium Growth

Updated Category News Views 80

Children’s media rarely gets a clean strategic move, but this one comes pretty close. Minno has signed a worldwide, multi-year agreement making it the exclusive faith-based streaming home for Listener Kids’ video library, while commissioning 66 new episodes for its own service. For a company trying to build a serious Christian family-media business, that is more than...

Continue Reading
APEC in Shenzhen Puts Trade Openness Back in Focus

Updated Category News Views 80

Shenzhen is hosting a familiar but consequential argument: prosperity gets harder to share when trade channels clog up. At the 33rd Asia-Pacific Economic Cooperation Economic Leaders' Meeting on November 18, President Xi Jinping used the opening of the APEC CEO Summit to argue for peace, openness, innovation, mutual benefit and support for the WTO-centered multilateral...

Continue Reading
HiTHIUM's 8-Hour Storage Pitch Faces Real Grid Tests

Updated Category News Views 136

Eight hours of stored electricity is where the sales brochure meets the ugly parts of the grid. HiTHIUM arrived at RE+ 2026 in Las Vegas, held November 17 through 19, with a broad storage pitch: systems ranging from two to eight hours, lithium-ion and sodium-ion chemistry, plus the software and validation work needed to make a battery plant behave when the local grid gets...

Continue Reading

Top 5 Most Recently Viewed Articles

Addgene Launches Innovative Antibody Characterization Platform

Updated Category News Views 109

Addgene Launches Innovative Antibody Characterization Platform Addgene, a visionary organization dedicated to enhancing scientific research, recently introduced a groundbreaking antibody characterization platform that draws from its extensive antibody catalog. This initiative aims to significantly advance the field of biomedical research by ensuring that antibodies are...

Continue Reading
Nishant Saxena Joins Jeune Aesthetics as CFO to Drive Growth

Updated Category News Views 294

Jeune Aesthetics Welcomes New Chief Financial Officer Jeune Aesthetics has taken a significant step forward by appointing Nishant Saxena as its Chief Financial Officer (CFO). This decision comes at a crucial time as the company prepares to advance its growth strategies and innovate in the field of medical aesthetics designed to combat aging skin. Understanding the...

Continue Reading
Organ Preservation Solutions Market to Reach $512.62 Million by 2031

Updated Category News Views 144

Growth of the Organ Preservation Solutions Market The organ preservation solutions market is experiencing significant growth as the global demand for organ transplantation rises. According to a comprehensive report from The Insight Partners, it is projected that this market will reach a remarkable $512.62 million by 2031 with a compound annual growth rate (CAGR) of 8.1%....

Continue Reading
Alpine Income Property Trust Secures $14.1 Million Mortgage Loan

Updated Category News Views 133

Alpine Income Property Trust Makes Strategic Mortgage Investment WINTER PARK, Fla. – Alpine Income Property Trust, Inc. (NYSE: PINE), a well-known real estate investment trust, has recently announced a significant investment by originating a first mortgage loan. The loan investment, amounting to $14.1 million, is secured by a luxury residential development featuring...

Continue Reading
Zenity Introduces New Framework for Securing GenAI Systems

Updated Category News Views 127

Zenity Introduces GenAI Attacks Matrix for Enhanced Security Zenity, a leader in the security domain for enterprise copilots and low-code development, has launched its innovative security framework known as the GenAI Attacks Matrix. This open-source initiative is inspired by the renowned MITRE ATLAS and developed with contributions from top security researchers worldwide,...

Continue Reading